
Patricia Ann Duffy
Examiner (ID: 7333)
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1806, 1648, 1802, 1645, 1818 |
| Total Applications | 1671 |
| Issued Applications | 766 |
| Pending Applications | 244 |
| Abandoned Applications | 672 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7662714
[patent_doc_number] => 20110311983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'FUIDI HERD MANAGEMENT SCHEMA'
[patent_app_type] => utility
[patent_app_number] => 13/221301
[patent_app_country] => US
[patent_app_date] => 2011-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8534
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20110311983.pdf
[firstpage_image] =>[orig_patent_app_number] => 13221301
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/221301 | Fuidi herd management schema | Aug 29, 2011 | Issued |
Array
(
[id] => 9003101
[patent_doc_number] => 20130224226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'INSECT BINDING ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 13/819326
[patent_app_country] => US
[patent_app_date] => 2011-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9660
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13819326
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/819326 | INSECT BINDING ANTIBODIES | Aug 24, 2011 | Abandoned |
Array
(
[id] => 7579727
[patent_doc_number] => 20110293610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-01
[patent_title] => 'ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO B LYMPHOCYTE STIMULATOR PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 13/209197
[patent_app_country] => US
[patent_app_date] => 2011-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 198992
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20110293610.pdf
[firstpage_image] =>[orig_patent_app_number] => 13209197
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/209197 | ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO B LYMPHOCYTE STIMULATOR PROTEIN | Aug 11, 2011 | Abandoned |
Array
(
[id] => 7711005
[patent_doc_number] => 20120003662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-05
[patent_title] => 'Methods and Kits for Detecting Mastitis'
[patent_app_type] => utility
[patent_app_number] => 13/190869
[patent_app_country] => US
[patent_app_date] => 2011-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16226
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13190869
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/190869 | Methods and Kits for Detecting Mastitis | Jul 25, 2011 | Abandoned |
Array
(
[id] => 8533536
[patent_doc_number] => 08309691
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-13
[patent_title] => 'Chlamydomonas intraflagellar transport 88 (IFT-88)'
[patent_app_type] => utility
[patent_app_number] => 13/188621
[patent_app_country] => US
[patent_app_date] => 2011-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 39644
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13188621
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/188621 | Chlamydomonas intraflagellar transport 88 (IFT-88) | Jul 21, 2011 | Issued |
Array
(
[id] => 7561752
[patent_doc_number] => 20110275585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-10
[patent_title] => 'TARGETED DELIVERY OF DRUGS, THERAPEUTIC NUCLEIC ACIDS AND FUNCTIONAL NUCLEIC ACIDS TO MAMMALIAN CELLS VIA INTACT KILLED BACTERIAL CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/184068
[patent_app_country] => US
[patent_app_date] => 2011-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 26096
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20110275585.pdf
[firstpage_image] =>[orig_patent_app_number] => 13184068
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/184068 | Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells | Jul 14, 2011 | Issued |
Array
(
[id] => 8624881
[patent_doc_number] => 08357375
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-22
[patent_title] => 'Process for the preparation and use of a bivalent vaccine against morphine-heroine addiction'
[patent_app_type] => utility
[patent_app_number] => 13/182634
[patent_app_country] => US
[patent_app_date] => 2011-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 19
[patent_no_of_words] => 19796
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13182634
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/182634 | Process for the preparation and use of a bivalent vaccine against morphine-heroine addiction | Jul 13, 2011 | Issued |
Array
(
[id] => 8606097
[patent_doc_number] => 20130011410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-10
[patent_title] => 'Egg White Antibodies for Prevention and Treatment of Specific Localized Intestinal Infections and Diseases Associated with a Pathogenic Organism or Molecule'
[patent_app_type] => utility
[patent_app_number] => 13/178017
[patent_app_country] => US
[patent_app_date] => 2011-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3824
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13178017
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/178017 | Egg White Antibodies for Prevention and Treatment of Specific Localized Intestinal Infections and Diseases Associated with a Pathogenic Organism or Molecule | Jul 6, 2011 | Abandoned |
Array
(
[id] => 8891141
[patent_doc_number] => 20130164325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-27
[patent_title] => 'CERAMIDE-LIKE GLYCOLIPID-ASSOCIATED BACTERIAL VACCINES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/808495
[patent_app_country] => US
[patent_app_date] => 2011-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 25670
[patent_no_of_claims] => 86
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13808495
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/808495 | CERAMIDE-LIKE GLYCOLIPID-ASSOCIATED BACTERIAL VACCINES AND USES THEREOF | Jul 5, 2011 | Abandoned |
Array
(
[id] => 7731641
[patent_doc_number] => 20120014993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'CLOSTRIDIUM TAENIOSPORUM SPORES AND SPORE APPENDAGES AS SURFACE DISPLAY HOSTS, DRUG DELIVERY DEVICES, AND NANOBIOTECHNOLOGICAL STRUCTURES'
[patent_app_type] => utility
[patent_app_number] => 13/163209
[patent_app_country] => US
[patent_app_date] => 2011-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17690
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20120014993.pdf
[firstpage_image] =>[orig_patent_app_number] => 13163209
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/163209 | CLOSTRIDIUM TAENIOSPORUM SPORES AND SPORE APPENDAGES AS SURFACE DISPLAY HOSTS, DRUG DELIVERY DEVICES, AND NANOBIOTECHNOLOGICAL STRUCTURES | Jun 16, 2011 | Abandoned |
Array
(
[id] => 7484568
[patent_doc_number] => 20110250223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-13
[patent_title] => 'HYBRID AND TANDEM EXPRESSION OF NEISSERIAL PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 13/159370
[patent_app_country] => US
[patent_app_date] => 2011-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11137
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20110250223.pdf
[firstpage_image] =>[orig_patent_app_number] => 13159370
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/159370 | Hybrid and tandem expression of Neisserial proteins | Jun 12, 2011 | Issued |
Array
(
[id] => 8264691
[patent_doc_number] => 20120164105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-28
[patent_title] => 'CONSTRUCTION OF A QUADRUPLE ENTEROTOXIN-DEFICIENT MUTANT OF BACILLUS THURINGIENSIS'
[patent_app_type] => utility
[patent_app_number] => 13/154857
[patent_app_country] => US
[patent_app_date] => 2011-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9479
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13154857
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/154857 | Construction of a quadruple enterotoxin-deficient mutant of Bacillus thuringiensis | Jun 6, 2011 | Issued |
Array
(
[id] => 9922320
[patent_doc_number] => 08980276
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-17
[patent_title] => 'Conjugates for the prevention or treatment of nicotine addiction'
[patent_app_type] => utility
[patent_app_number] => 13/151590
[patent_app_country] => US
[patent_app_date] => 2011-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 23
[patent_no_of_words] => 30191
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13151590
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/151590 | Conjugates for the prevention or treatment of nicotine addiction | Jun 1, 2011 | Issued |
Array
(
[id] => 8339714
[patent_doc_number] => 08241631
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-14
[patent_title] => 'Human binding molecules having killing activity against enterococci and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/068784
[patent_app_country] => US
[patent_app_date] => 2011-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 28340
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13068784
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/068784 | Human binding molecules having killing activity against enterococci and uses thereof | May 18, 2011 | Issued |
Array
(
[id] => 7586773
[patent_doc_number] => 20110281283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'YEAST CELL WALL COMPONENTS AND DETECTION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/107716
[patent_app_country] => US
[patent_app_date] => 2011-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 27634
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20110281283.pdf
[firstpage_image] =>[orig_patent_app_number] => 13107716
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/107716 | YEAST CELL WALL COMPONENTS AND DETECTION THEREOF | May 12, 2011 | Abandoned |
Array
(
[id] => 6064890
[patent_doc_number] => 20110201791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 13/093976
[patent_app_country] => US
[patent_app_date] => 2011-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19049
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20110201791.pdf
[firstpage_image] =>[orig_patent_app_number] => 13093976
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/093976 | MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION | Apr 25, 2011 | Abandoned |
Array
(
[id] => 7500390
[patent_doc_number] => 20110262926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'EXTRACTING LOW CONCENTRATIONS OF BACTERIA FROM A SAMPLE'
[patent_app_type] => utility
[patent_app_number] => 13/091534
[patent_app_country] => US
[patent_app_date] => 2011-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8885
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20110262926.pdf
[firstpage_image] =>[orig_patent_app_number] => 13091534
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/091534 | Extracting low concentrations of bacteria from a sample | Apr 20, 2011 | Issued |
Array
(
[id] => 7656455
[patent_doc_number] => 20110305724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-15
[patent_title] => 'IMMUNOTHERAPEUTIC, ANTI-TUMORIGENIC COMPOSITIONS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/090159
[patent_app_country] => US
[patent_app_date] => 2011-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16597
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20110305724.pdf
[firstpage_image] =>[orig_patent_app_number] => 13090159
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/090159 | IMMUNOTHERAPEUTIC, ANTI-TUMORIGENIC COMPOSITIONS AND METHODS OF USE THEREOF | Apr 18, 2011 | Abandoned |
Array
(
[id] => 8779690
[patent_doc_number] => 20130101665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'SELF-ASSEMBLING HALF-ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 13/640202
[patent_app_country] => US
[patent_app_date] => 2011-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 18235
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13640202
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/640202 | SELF-ASSEMBLING HALF-ANTIBODIES | Apr 7, 2011 | Abandoned |
Array
(
[id] => 8251871
[patent_doc_number] => 20120156196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-21
[patent_title] => 'ANTI-ANTHRAX ANTIBODY, FORMULATIONS THEREOF, AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 13/076082
[patent_app_country] => US
[patent_app_date] => 2011-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15439
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20120156196.pdf
[firstpage_image] =>[orig_patent_app_number] => 13076082
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/076082 | Methods of preventing or treating anthrax using anti-anthrax antibodies | Mar 29, 2011 | Issued |